The Deal quoted Member Theresa Carnegie in a recent article about how regulatory pressure on pharmacy benefit managers (PBMs) has sparked innovation and opened up investment opportunities in the industry. Increased scrutiny of larger PBMs over concerns about competition and drug prices has prompted newer PBMs to emphasize transparency.

“There is a view that the traditional PBM model is not satisfying the public or regulators. And with that, regulation becomes the opportunity for change and disruption,” Theresa says. 

 

Source

The Deal